Yuhan USA Corporation was established in January, 2018 as a wholly owned subsidiary of Yuhan Corporation, Korea’s largest pharmaceutical company with a 93-year heritage.

As an outpost of Yuhan’s globalization strategy, Yuhan USA is seeking new opportunities to expand its business domain through searching new drug materials and companies that match with Yuhan’s targeted therapeutic areas under its open innovation platform.